Am Soc Clin Oncol Educ Book
Dr. Kriti Mittal, MD
- Medicare services, 2024
- 680
- Medicare patients, 2024
- 242
- Part D claims, 2024
- 905
- Publications
- 24
- Clinical trials
- 3
- Practice address
- 55 North Ave, Mendon, MA 01756
- Practice phone
- Call (508) 334-1000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Umass Memorial Medical Center
Mendon, Massachusetts
Find Dr. Mittal's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kriti Mittal is a hematologist and oncologist in Mendon, Massachusetts
Dr. Mittal practices at Umass Memorial Medical Center in Mendon, Massachusetts.
Dr. Mittal's NPI, 1770740649, was assigned on May 19, 2008. Dr. Mittal holds Massachusetts license 244896.
- NPI
- 1770740649NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7214120971
- NPI enumeration date
- May 19, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (508) 334-1000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 47
- Medical school graduation
- 2005
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Kriti Mittal practices at Umass Memorial Medical Center in Mendon, Massachusetts
Dr. Mittal's primary practice is Umass Memorial Medical Center, at 55 North Ave, Mendon, MA 01756 in Worcester County. The practice phone is (508) 334-1000.
- Umass Memorial Medical Center55 North Ave, Mendon, MA 01756 · Worcester CountyPhone(508) 334-1000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Kriti Mittal is affiliated with 5 sites of care and 1 medical group
Dr. Mittal's primary practice is Umass Memorial Medical Center in Mendon, Massachusetts. Dr. Mittal is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Dr. Mittal to 3 more hospitals, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Kriti Mittal's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mittal practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Umass Memorial Medical Center | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kriti Mittal is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Mittal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mittal is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Mittal
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kriti Mittal billed Medicare for 680 services in 2024
CMS data shows 680 Medicare services from Dr. Mittal across 7 procedure codes in 2024, for 242 Medicare patients. Medicare paid $56,807 for them.
Dr. Mittal's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 6202024: 68010%
Where Dr. Mittal's Medicare services took place, 2024
- In an office22533%
- In a facility45567%
Dr. Mittal compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Mittal
- Massachusetts median
- Medicare services
- 680vs 49537% above
- Medicare patients
- 242vs 20021% above
- Part D claims
- 739vs 1514.9 times
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Mittal's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mittal?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mittal and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Kriti Mittal treated 242 Medicare patients in 2024, average age 76
CMS counts 242 Medicare patients who saw Dr. Mittal in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have cancer, and 75% have high blood pressure. 26% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mittal's median patient age at 76, with 13% women.
Dr. Mittal's Medicare patients by age, 2024
Dr. Mittal's Medicare patients by sex, 2024
- Women4920%
- Men19380%
Chronic conditions among Dr. Mittal's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis37%
- Diabetes36%
- Ischemic heart disease35%
- Chronic kidney disease34%
- COPD24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mittal's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 76
Patient panel by sex, all payers
- Women13%
- Men87%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Kriti Mittal wrote 905 Medicare Part D claims in 2024
In 2024, Dr. Mittal wrote 905 Medicare Part D claims for 124 patients. 63% of them were for generic drugs. CMS names the drug for 739 of them, across 18 drugs with 11 or more claims each, at $4,331,559 in total drug cost. In 2023, CMS named 669 claims across 16 drugs.
Dr. Mittal's Part D claims by kind of drug, 2024
- Generic573 claims63%
- Brand-name332 claims37%
Dr. Mittal's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mittal's Part D claims, 2024
- Opioids3%23 of 905 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6692024: 73910%
Drugs named by CMS: 18 in 2024, 16 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Kriti Mittal scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mittal for performance year 2024, reported through an alternative payment model (APM). Dr. Mittal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mittal as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Mittal's MIPS scores, performance year 2024
- 100of 100Final score
- 83of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Kriti Mittal has 24 publications on record
Dmand AI links 24 papers to Dr. Mittal, published from 2010 to 2025. 2014 was the busiest year, with 5. The most frequent topics are Carcinoma, Transitional Cell, Immunotherapy and Kidney Neoplasms. Dr. Mittal has published most often in Med. Dr. Mittal's most frequent co-authors are Monika Joshi, MD, Jan Cerny, MD and Lacey J. McIntosh, DO, MPH.
Dr. Mittal's papers by year, 2012 to 2025
Topics Dr. Mittal writes about most
- Carcinoma, Transitional Cell
- Immunotherapy
- Kidney Neoplasms
- Antibodies, Monoclonal, Humanized
- Urinary Bladder Neoplasms
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Renal Cell
Dr. Mittal's most frequent co-authors
- Monika Joshi, MD3 shared papers
- Jan Cerny, MD2 shared papers
- Lacey J. McIntosh, DO, MPH2 shared papers
Recent publications by Dr. Mittal
Enfortumab-vedotin use for urothelial carcinoma in two patients on hemodialysis (opens in a new tab)
J Oncol Pharm Pract
Front Public Health
See who Dr. Mittal researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mittal works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kriti Mittal has worked on 3 clinical trials
Dmand AI links Dr. Mittal to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Carcinoma, Renal Cell, Neoplasm Metastasis and Kidney Neoplasms.
Clinical trials with Dr. Mittal by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Mittal's trials
- Carcinoma, Renal Cell
- Neoplasm Metastasis
- Kidney Neoplasms
- Neoplastic Processes
Investigators on the most trials with Dr. Mittal
- Monika Joshi, MD2 shared trials
- Prateek Mendiratta, MD2 shared trials
- Vivek K. Narayan, MD2 shared trials
Recent clinical trials with Dr. Mittal
Cabazitaxel With Abiraterone Versus Abiraterone Alone Randomized Trial for Extensive Disease Following Docetaxel: The CHAARTED2 Trial (opens in a new tab)
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kriti Mittal received $12,475 in industry payments from 2016 to 2025
CMS Open Payments shows 26 general payments to Dr. Mittal from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Myovant Sciences Inc. paid the most, $3,840.
General payments to Dr. Mittal by program year, 2016 to 2025
General payments to Dr. Mittal by kind, 2016 to 2025
- Consulting fees$7,53360%
- Speaker and faculty fees$3,84031%
- Food and beverage$1,0008%
- Education$1031%
Companies that paid Dr. Mittal the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Kriti Mittal's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kriti Mittal
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kriti Mittal's NPI number?
Dr. Kriti Mittal's NPI number is 1770740649. It was assigned on May 19, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Kriti Mittal?
Dr. Kriti Mittal is a hematologist and oncologist in Mendon, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Kriti Mittal practice?
Dr. Mittal practices at 55 North Ave, Mendon, MA 01756. Dr. Mittal's primary practice is Umass Memorial Medical Center in Mendon, Massachusetts. Dmand AI also links Dr. Mittal to 3 hospitals.
What is Dr. Kriti Mittal's office phone number?
The practice phone on file for Dr. Mittal is (508) 334-1000.
What is Dr. Kriti Mittal's medical license number?
Dr. Mittal holds Massachusetts license 244896.
Which hospitals is Dr. Kriti Mittal affiliated with?
Dr. Mittal is affiliated with UMass Memorial Medical Center - University Campus. Dmand AI links Dr. Mittal to 3 more hospitals.
What medical group is Dr. Kriti Mittal part of?
Dr. Mittal is linked to UMass Memorial Medical Group.
Does Dr. Kriti Mittal accept Medicare?
Yes. CMS data shows Dr. Mittal billed Medicare for 680 services in 2024, and Dr. Mittal accepts Medicare assignment.
Does Dr. Kriti Mittal offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mittal as offering telehealth services.
What is Dr. Kriti Mittal's MIPS score?
Dr. Mittal's MIPS final score for performance year 2024 is 100 out of 100, reported through an alternative payment model (APM).
Show 7 more questionsShow fewer questions
How many Medicare patients does Dr. Kriti Mittal see?
CMS counts 242 Medicare patients who saw Dr. Mittal in 2024, with an average age of 76.
What services does Dr. Kriti Mittal bill to Medicare?
In 2024, Dr. Mittal's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and office visit, established patient (99213).
What drugs does Dr. Kriti Mittal prescribe most?
In 2024 Medicare Part D data, Dr. Mittal's most prescribed drugs by claims were Abiraterone Acetate, Prednisone and Xtandi.
Has Dr. Kriti Mittal received payments from drug or device companies?
CMS Open Payments shows $12,475 in general payments to Dr. Mittal from 11 companies from 2016 to 2025. The largest total came from Myovant Sciences Inc.
How long has Dr. Kriti Mittal been practicing?
Dr. Mittal graduated from medical school in 2005, 21 years ago.
Does Dr. Kriti Mittal do research?
Dmand AI links 24 publications to Dr. Mittal, published from 2010 to 2025. Dr. Mittal has worked on 3 clinical trials.
Who does Dr. Kriti Mittal publish with?
Dr. Mittal's most frequent co-authors are Monika Joshi, MD (3 shared papers), Jan Cerny, MD (2 shared papers) and Lacey J. McIntosh, DO, MPH (2 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card